You are here

  • Home
  • Archive
  • Volume 12, Issue 3
  • Percutaneous cryoablation of a solitary, soft-tissue metastasis from renal cell carcinoma: a new local minimal invasive curative treatment

Article Text

Article menu
Download PDFPDF
Novel treatment (new drug/intervention; established drug/procedure in new situation)
CASE REPORT
Percutaneous cryoablation of a solitary, soft-tissue metastasis from renal cell carcinoma: a new local minimal invasive curative treatment
  1. Theresa Junker1,2,
  2. Benjamin Schnack Rasmussen1,3,
  3. Anja Toft2 and
  4. Ole Graumann1,3
  1. 1 Radiology Research and Innovation Unit, Department of Radiology, Odense, Denmark
  2. 2 Urology Department, Odense University Hospital, Odense, Denmark
  3. 3 Institute of Clinical Research, University of Southern Denmark, Odense, Denmark
  1. Correspondence to Dr Ole Graumann, ograumann{at}health.sdu.dk

Abstract

Cryoablation is a well-established treatment option, proven to be successful in treating local renal cell carcinoma (RCC). We treated a 67-year-old man in an outpatient setting with late onset of a 25 mm solitary soft-tissue metastasis of from RCC with cryoablation. The treatment was performed under sedation and in local anaesthesia. There were no complications during the procedure. The patient did not experience any adverse effects to the treatment. He was able to resume his normal daily routines the day after his treatment. A follow-up CT scan at 3, 8 and 12 months after treatment reported sufficient cryoablation and no sign of recurrence or other metastases.

  • cancer intervention
  • urological cancer

http://dx.doi.org/10.1136/bcr-2018-227129

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors Study design, planning and reporting: OG. Study conception: TJ, OG, BSR and AT. Data acquisition: TJ, OG, BSR and AT. Quality control of data and algorithms: TJ, OG, BSR and AT. Data analysis and interpretation: TJ, OG, BSR and AT. Statistical analysis: None. Manuscript preparation: TJ, OG, BSR and AT. Manuscript editing: TJ, OG, BSR and AT. Manuscript review: TJ, OG, BSR and AT. All authors: OG, TJ, BSR and AT.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; externally peer reviewed.

    • Patient consent for publication Obtained.